VXRT
Vaxart, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:A-
Company Profile
CEO
Steven Lo
IPO Date
1981-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Vaxart, Inc.
CEO
Steven Lo
IPO Date
1981-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 31,395 |
| $0.61 |
| 1 May 2026 | BREITMEYER JAMES B | director | A-Award | Acquired | 78,800 | $0.00 |
| 1 May 2026 | BREITMEYER JAMES B | director | A-Award | Acquired | 157,400 | $0.74 |
| 1 May 2026 | BREITMEYER JAMES B | director: | Disposed | 0 | $0.00 |
| 31 Mar 2026 | Tucker Sean | SVP, Chief Scientific Officer | F-InKind | Disposed | 3,924 | $0.65 |
| 31 Mar 2026 | Cummings James F. | Chief Medical Officer | F-InKind | Disposed | 3,292 | $0.65 |
| 26 Mar 2026 | Berg Edward B | SVP, General Counsel | F-InKind | Disposed | 36,418 | $0.69 |
| 26 Mar 2026 | Cummings James F. | Chief Medical Officer | F-InKind | Disposed | 30,551 | $0.69 |
| 26 Mar 2026 | Lo Steven | director, officer: President, Chief Exec Officer | F-InKind | Disposed | 126,028 | $0.69 |